Trexquant Investment LP Kura Oncology, Inc. Transaction History

Trexquant Investment LP

$8.01 Billion
Q1 2025

A detailed history of Trexquant Investment LP transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 685,970 shares of KURA stock, worth $4.51 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

685,970

Previous 566,945 20.99%

Holding current value

$4.51 Million

Previous $4.94 Million 8.32%

% of portfolio

0.06%

Previous 0.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$6.6 - $9.05 $785,565 - $1.08 Million	119,025 Added 20.99%	685,970 $4.53 Million
Q4 2024 Feb 12, 2025	BUY	$8.51 - $19.21 $4.33 Million - $9.77 Million	508,362 Added 867.76%	566,945 $4.94 Million
Q3 2024 Nov 12, 2024	BUY	$18.57 - $23.23 $83,917 - $104,976	4,519 Added 8.36%	58,583 $1.14 Million
Q2 2024 Aug 13, 2024	BUY	$17.53 - $22.98 $619,825 - $812,526	35,358 Added 189.02%	54,064 $1.11 Million
Q1 2024 May 14, 2024	SELL	$13.42 - $23.53 $608,207 - $1.07 Million	-45,321 Reduced 70.78%	18,706 $398,000
Q4 2023 Feb 09, 2024	BUY	$7.58 - $14.38 $207,024 - $392,746	27,312 Added 74.39%	64,027 $920,000
Q3 2023 Nov 13, 2023	SELL	$8.44 - $11.86 $393,371 - $552,770	-46,608 Reduced 55.94%	36,715 $334,000
Q2 2023 Aug 11, 2023	BUY	$9.62 - $13.99 $801,567 - $1.17 Million	83,323 New	83,323 $881,000
Q3 2022 Nov 14, 2022	BUY	$12.01 - $19.45 $406,730 - $658,693	33,866 Added 171.26%	53,641 $733,000
Q2 2022 Aug 11, 2022	BUY	$10.71 - $18.33 $211,790 - $362,475	19,775 New	19,775 $362,000
Q1 2022 May 13, 2022	SELL	$11.78 - $16.98 $162,187 - $233,780	-13,768 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.22 - $19.57 $12,317 - $19,726	1,008 Added 7.9%	13,768 $193,000
Q3 2021 Nov 12, 2021	SELL	$15.42 - $21.72 $174,184 - $245,349	-11,296 Reduced 46.96%	12,760 $239,000
Q2 2021 Aug 12, 2021	BUY	$20.85 - $29.88 $339,771 - $486,924	16,296 Added 210.0%	24,056 $502,000
Q1 2021 May 13, 2021	SELL	$24.75 - $39.14 $361,721 - $572,031	-14,615 Reduced 65.32%	7,760 $219,000
Q4 2020 Feb 11, 2021	BUY	$29.0 - $41.62 $648,875 - $931,247	22,375 New	22,375 $731,000
Q3 2020 Nov 06, 2020	SELL	$16.3 - $30.64 $277,116 - $520,910	-17,001 Closed	0 $0
Q2 2020 Aug 07, 2020	SELL	$7.95 - $18.81 $111,975 - $264,938	-14,085 Reduced 45.31%	17,001 $277,000
Q1 2020 May 08, 2020	BUY	$6.45 - $14.04 $121,421 - $264,303	18,825 Added 153.54%	31,086 $309,000
Q4 2019 Feb 12, 2020	BUY	$12.97 - $15.94 $159,025 - $195,440	12,261 New	12,261 $169,000
Q4 2018 Feb 13, 2019	SELL	$10.6 - $17.49 $131,397 - $216,806	-12,396 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$16.65 - $21.85 $206,393 - $270,852	12,396 New	12,396 $217,000

Others Institutions Holding KURA

# of Institutions

190

Shares Held

79M

Call Options Held

76K

Put Options Held

85.8K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $439M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Kura Oncology, Inc. Transaction History